FDA Approves Cannabidiol for Tuberous Sclerosis Complex FDA Approves Cannabidiol for Tuberous Sclerosis Complex
The US Food and Drug Administration has expanded its approval for cannabidiol (Epidiolex) oral solution to also treat seizures in tuberous sclerosis complex for patients aged 1 year and older.FDA Approvals
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news
More News: Brain | Food and Drug Administration (FDA) | Neurology | Neurosurgery | Tuberous Sclerosis